Allergan

Allergan (AGN) is a leading pharmaceuticals company involved with pharmaceuticals, over-the-counter products, eye care, and aesthetics products.

Key Developments for Allergan in 2Q17

Key developments during 2Q17

The key developments reported by Allergan during 2Q17 are as follows:

  • On June 27, 2017, Allergan launched REFRESH OPTIVE MEGA-3 drops, which are artificial tear drops formulated with flaxseed oil and castor oil to protect tears from evaporating while strengthening the lipid layer in patients with Meibomian Gland Dysfunction who are suffering from dry eyes.
  • On June 7, 2017, Allergan announced the acquisition of Keller Medical, a privately held medical device company, for Keller Funnel, which is a cone-shaped, lubricated plastic funnel used during breast augmentation or reconstruction.
  • On April 28, 2017, Allergan completed the acquisition of Zeltiq Aesthetics, a medical technology company that developed CoolSculpting, a proprietary controlled cooling fat reducing treatment.
  • On April 25, 2017, the US Food and Drug Administration (or FDA) granted marketing authorization to TrueTear Intranasal Tear Neurostimulator, a handheld stimulator used to increase tear production during neurostimulation.
  • On April 20, 2017, Allergan announced a collaboration with Target PharmaSolutions in order to advance the research associated with nonalcoholic steatohepatitis (or NASH).
  • On April 18, 2017, Allergan announced an agreement with Novartis (NVS) to conduct the Phase 2b study in order to evaluate the use of Allergan’s Cenicriviroc and Novartis’s lead FXR agonist for the treatment of NASH. The study evaluates the safety, efficacy, and tolerability of this multi-therapy treatment.

To divest the company-specific risks, investors can consider ETFs like the Vanguard Healthcare ETF (VHT), which holds 2.2% of its total assets in Allergan (AGN), 2.7% in Gilead Sciences (GILD), 2.9% in Celgene (CELG), and 3.2% in AbbVie (ABBV).

Latest articles

Marathon Petroleum (MPC) stock has been tumbling in Q3, driven by geopolitical tensions, oil price uncertainty, and weaker refining conditions.

This week, AT&T CEO Randall Stephenson noted that AT&T (T) is on track to reduce its leverage multiple to about 2.5x by the end of this year.

Jeff Bezos announced that Amazon had placed an order of 100,000 electric delivery vans from Michigan-based startup Rivian.

Bad news on the trade war front appears to have led to a fall in the broader US equity markets today. Cannabis ETFs were also trading in the red.

Energy Transfer (ET) stock has recovered in the last two trading sessions after investors hammered it on its plans to acquire SemGroup (SEMG).

Software-as-a-service company Datadog (DDOG) made a smashing debut on Wall Street yesterday. After its IPO, DDOG's shares surged 40% in intraday trading.